Sfoglia per Titolo
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives
2003-01-01 Vicenzi, E; Gatti, A; Ghezzi, S; Oreste, P; Zoppetti, G; Poli, Guido
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis.
2012-01-01 Clementi, Nicola; Criscuolo, Elena; Castelli, Matteo; Clementi, Massimo
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine
2013-01-01 Castelli, M.; Clementi, Nicola; Mancini, Nicasio; Clementi, Massimo; Burioni, R.
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses
2013-01-01 Criscuolo, E; Cappelletti, F; Clementi, N; Mancini, N; Sautto, Ga; Diotti, Ra; Clementi, M and Burioni R
Broca's Area and Lexical-Semantic Processing
2009-01-01 Cappa, STEFANO FRANCESCO; Perani, DANIELA FELICITA L.
Broca’s Area as a Pre-articulatory Phonetic Encoder: Gating the Motor Program
2018-01-01 Ferpozzi, Valentina; Fornia, Luca; Montagna, Marcella; Siodambro, Chiara; Castellano, Antonella; Borroni, Paola; Riva, Marco; Rossi, Marco; Pessina, Federico; Bello, Lorenzo; Cerri, Gabriella
Broken affordances, broken objects: a TMS study
2009-01-01 Buccino, G; Sato, M; Cattaneo, L; Roda', F; Riggio, L
Broken heart syndrome: tako-tsubo cardiomyopathy
2009-01-01 Latib, Azeem; Ielasi, Alfonso; Montorfano, M; Colombo, Antonio
Brolucizimab—leading an era of structural revolution for long-term VEGF suppression
2019-01-01 Sharma, Ashish; Kumar, Nilesh; Kuppermann, Baruch D.; Bandello, Francesco
Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials
2022-01-01 Singer, M.; Khanani, A. M.; Wolf, A.; Flores, R.; Chhablani, J.; B, G. B.; Clemens, A.; Gedif, K.; Liu, X.; Mulyukov, Z.; Querques, G.
Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
2020-01-01 Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Regillo, Carl D.
Brolucizumab and immunogenicity
2020-01-01 Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat
Brolucizumab in polypoidal choroidal vasculopathy
2022-01-01 Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Kuppermann, Baruch D; Loewenstein, Anat; Bandello, Francesco
Brolucizumab ─ termination of 4 weekly trials ─ rebalancing the immunogenicity risk
2022-01-01 Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sahyoun, Jean-Yves; Kuppermann, Baruch D; Bandello, Francesco
Brolucizumab-foreseeable workflow in the current scenario
2021-01-01 Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Kuppermann, Baruch D; Bandello, Francesco; Regillo, Carl D; Boyer, David; Nguyen, Quan Dong
Brolucizumab-key learnings from HAWK and HARRIER
2020-01-01 Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat
Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world
2020-01-01 Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Singh, Sonali; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat
Brolucizumab: is extended VEGF suppression on the horizon?
2019-01-01 Sharma, Ashish; Kumar, Nilesh; Kuppermann, Baruch D; Loewenstein, Anat; Bandello, Francesco
Brolucizumab: the road ahead
2020-01-01 Sharma, Ashish; Kumar, Nilesh; Bandello, Francesco; Kuppermann, Baruch D; Loewenstein, Anat; Regillo, Carl D
Brolucizumab—another anti-VEGF or beyond
2020-01-01 Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives | 1-gen-2003 | Vicenzi, E; Gatti, A; Ghezzi, S; Oreste, P; Zoppetti, G; Poli, Guido | |
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. | 1-gen-2012 | Clementi, Nicola; Criscuolo, Elena; Castelli, Matteo; Clementi, Massimo | |
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine | 1-gen-2013 | Castelli, M.; Clementi, Nicola; Mancini, Nicasio; Clementi, Massimo; Burioni, R. | |
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses | 1-gen-2013 | Criscuolo, E; Cappelletti, F; Clementi, N; Mancini, N; Sautto, Ga; Diotti, Ra; Clementi, M and Burioni R | |
Broca's Area and Lexical-Semantic Processing | 1-gen-2009 | Cappa, STEFANO FRANCESCO; Perani, DANIELA FELICITA L. | |
Broca’s Area as a Pre-articulatory Phonetic Encoder: Gating the Motor Program | 1-gen-2018 | Ferpozzi, Valentina; Fornia, Luca; Montagna, Marcella; Siodambro, Chiara; Castellano, Antonella; Borroni, Paola; Riva, Marco; Rossi, Marco; Pessina, Federico; Bello, Lorenzo; Cerri, Gabriella | |
Broken affordances, broken objects: a TMS study | 1-gen-2009 | Buccino, G; Sato, M; Cattaneo, L; Roda', F; Riggio, L | |
Broken heart syndrome: tako-tsubo cardiomyopathy | 1-gen-2009 | Latib, Azeem; Ielasi, Alfonso; Montorfano, M; Colombo, Antonio | |
Brolucizimab—leading an era of structural revolution for long-term VEGF suppression | 1-gen-2019 | Sharma, Ashish; Kumar, Nilesh; Kuppermann, Baruch D.; Bandello, Francesco | |
Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials | 1-gen-2022 | Singer, M.; Khanani, A. M.; Wolf, A.; Flores, R.; Chhablani, J.; B, G. B.; Clemens, A.; Gedif, K.; Liu, X.; Mulyukov, Z.; Querques, G. | |
Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD) | 1-gen-2020 | Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Regillo, Carl D. | |
Brolucizumab and immunogenicity | 1-gen-2020 | Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat | |
Brolucizumab in polypoidal choroidal vasculopathy | 1-gen-2022 | Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Kuppermann, Baruch D; Loewenstein, Anat; Bandello, Francesco | |
Brolucizumab ─ termination of 4 weekly trials ─ rebalancing the immunogenicity risk | 1-gen-2022 | Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Sahyoun, Jean-Yves; Kuppermann, Baruch D; Bandello, Francesco | |
Brolucizumab-foreseeable workflow in the current scenario | 1-gen-2021 | Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Kuppermann, Baruch D; Bandello, Francesco; Regillo, Carl D; Boyer, David; Nguyen, Quan Dong | |
Brolucizumab-key learnings from HAWK and HARRIER | 1-gen-2020 | Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat | |
Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world | 1-gen-2020 | Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Singh, Sonali; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat | |
Brolucizumab: is extended VEGF suppression on the horizon? | 1-gen-2019 | Sharma, Ashish; Kumar, Nilesh; Kuppermann, Baruch D; Loewenstein, Anat; Bandello, Francesco | |
Brolucizumab: the road ahead | 1-gen-2020 | Sharma, Ashish; Kumar, Nilesh; Bandello, Francesco; Kuppermann, Baruch D; Loewenstein, Anat; Regillo, Carl D | |
Brolucizumab—another anti-VEGF or beyond | 1-gen-2020 | Sharma, Ashish; Parachuri, Nikulaa; Kumar, Nilesh; Sharma, Rohini; Bandello, Francesco; Kuppermann, Baruch D.; Loewenstein, Anat |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile